posit path set beyond
addit note guidanc dentspli provid rosi tone earn call
clear plan layout compani thought move
regard compani intern growth expect compani expect see
benefit bp absenc destock increment benefit
new product launch exact quantif provid rest
seemingli come core market growth compani expect gross margin
expand bp y/i sale expect improv oper expens
expect declin lead compani expect ebit
margin bp improv promisingli
compani guidanc factor includ cost cut initi remain
cost cut initi docket help compani build
oper incom margin end compani plan
employe end achiev full employe reduct level end
addit compani continu anticip divest under-perform
asset move forward may occur may increment
slow top-lin growth help acceler bottom line note
exits/divestitur expect gener save mln take altogeth
result guidanc set reason path forward compani addit
opportun futur growth
rais estim rais pt follow compani result rais
estim price target rais ep
rais ep see compani achiev
cost cut initi laid restructur plan novemb
shift valuat basi rais pe multipl
acceler ep growth rais pt new
ep
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
equal weight equal weight
compani continu re-ori manag
reshuffl continu cut cost
larg bake stock
upsid case see multipl expans sale
improv restructur initi take hold ep
revenu growth come plan minim
margin expans due lower revenu would
lead multipl contract
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
compani saw good traction relat primescan new exist user
compani continu focu new user base regard upgrad plan
exist user compani believ may introduc upgrad path back half
year depend upon stock demand compani may
introduc upgrad path year
compani anticip announc portfolio reduct next month
current size unknown manag indic would
similar size compani announc thu far mln sale relat
divestitur thu far divestitures/exit announc thu far compani expect
yield mln save primarili oper expens reduct
regard compani sale forc reorient compani larg kept shift
us howev compani anticip expand intern market
cours implant market compani believ market grow
rang implant busi make progress grow may
necessarili achiev market growth rate compani confid destock
behind better visibl channel
dentspli excl mlnfx marginimprov bp y/yopexbelow levelsebit reduc revenu mlnoffset mln less destock revenue expect lower sg higher barclay
 annual revenu model mil xrayxrayxrayxrayreport revenu revenu ex preciou metal dentspli revenu ex preciou metal dentspli revenu segment sale pro forma merger dental non-gaap revenu ex changedent non-gaap revenu ex barclay
 organ intern cc sale growthpfpfpfpfpfpfpfpforgan intern cc revenu sale revenu growth ex acquisit discontinu currenc constant currenc fx sale growth report sale organ intern cc sale growth currenc sale growth barclay
 annual incom statement revenu ex preciou excl revenu ex preciou oper addback excl amort addback check excl intang asset revenu ex preciou ens rate interest earn affili check ep fulli dilut share growth excl per barclay
 annual revenu model mil xrayxrayxrayreport revenu revenu ex preciou metal dentspli revenu ex preciou metal dentspli revenu segment sale pro forma merger dental non-gaap revenu ex changedent non-gaap revenu ex barclay
 annual incom statement revenu ex preciou excl revenu ex preciou oper addback excl amort addback check excl intang asset revenu ex preciou ens rate interest earn affili check ep fulli dilut share growth excl per barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
